Clinical biomarkers for hypoxia targeting
QT Le, D Courter - Cancer and Metastasis Reviews, 2008 - Springer
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
[引用][C] Clinical biomarkers for hypoxia targeting: Biomarkers for clinical trials using molecular inhibitors and radiotherapy: state-of-the-art approaches
QT LE, D COURTER - Cancer metastasis reviews, 2008 - pascal-francis.inist.fr
Clinical biomarkers for hypoxia targeting : Biomarkers for clinical trials using molecular
inhibitors and radiotherapy: state-of-the-art approaches CNRS Inist Pascal-Francis CNRS …
inhibitors and radiotherapy: state-of-the-art approaches CNRS Inist Pascal-Francis CNRS …
Clinical biomarkers for hypoxia targeting.
QT Le, D Courter - Cancer Metastasis Reviews, 2008 - europepmc.org
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
Clinical biomarkers for hypoxia targeting
QT Le, D Courter - Cancer and Metastasis Reviews, 2008 - infona.pl
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
[HTML][HTML] Clinical Biomarkers for Hypoxia Targeting
QT Le, D Courter - Cancer metastasis reviews, 2008 - ncbi.nlm.nih.gov
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
Clinical biomarkers for hypoxia targeting
Q Le, D Courter - Cancer and Metastasis Reviews, 2008 - search.proquest.com
Clinical biomarkers for hypoxia targeting Page 1 Cancer Metastasis Rev (2008) 2713517362
DOl 10.1007/s10555—008—9l44—9 Clinical biomarkers for hypoxia targeting Quynh-Thu Le …
DOl 10.1007/s10555—008—9l44—9 Clinical biomarkers for hypoxia targeting Quynh-Thu Le …
Clinical biomarkers for hypoxia targeting
QT Le, D Courter - Cancer metastasis reviews, 2008 - pubmed.ncbi.nlm.nih.gov
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
[引用][C] Clinical biomarkers for hypoxia targeting
QT Le, D Courter - Cancer and Metastasis Reviews, 2008 - cir.nii.ac.jp
[PDF][PDF] Clinical Biomarkers for Hypoxia Targeting
QT Le, D Courter - Cancer Metastasis Rev, 2008 - academia.edu
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
Clinical biomarkers for hypoxia targeting.
QT Le, D Courter - Cancer Metastasis Reviews, 2008 - europepmc.org
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …
factor for tumor progression and treatment resistance in solid tumors. Because hypoxic …